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Bacteria have evolved specific adaptive responses to cope with changing environments.
These adaptations include stress response phenotypes with dynamic modifications of
the bacterial cell envelope and generation of membrane vesicles (MVs). The obligate
intracellular bacterium, Chlamydia trachomatis, typically has a biphasic lifestyle, but can
enter into an altered growth state typified by morphologically aberrant chlamydial forms,
termed persistent growth forms, when induced by stress in vitro. How C. trachomatis can
adapt to a persistent growth state in host epithelial cells in vivo is not well understood, but
is an important question, since it extends the host-bacterial relationship in vitro and has
thus been indicated as a survival mechanism in chronic chlamydial infections. Here, we
review recent findings on the mechanistic aspects of bacterial adaptation to stress with
a focus on how C. trachomatis remodels its envelope, produces MVs, and the potential
important consequences of MV production with respect to host-pathogen interactions.
Emerging data suggest that the generation of MVs may be an important mechanism for
C. trachomatis intracellular survival of stress, and thus may aid in the establishment of a
chronic infection in human genital epithelial cells.
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INTRODUCTION
Chlamydia trachomatis serovars D-K account for the most preva-
lent bacterial sexually transmitted infections (STIs) worldwide.
Despite aggressive control efforts, C. trachomatis infections have
continued to constitute a serious public health risk (World Health
Organization, 2011; Rekart et al., 2013). Infection may result in
cervicitis, and in some women, C. trachomatis may ascend into
the endometrium and Fallopian tubes, where it can establish a
chronic infection leading to diseases such as pelvic inflammatory
disease (PID), ectopic pregnancy, and infertility. C. trachoma-
tis infections of women also pose a risk to infants, as infants
born from mothers with C. trachomatis infections can develop
conjunctivitis and/or pneumonia. Finally, epidemiological evi-
dence indicates that C. trachomatis infection of the reproductive
tract also may increase the risk of HIV transmission, making the
study and understanding of the pathogenicity of this bacterium
imperative.
In adapting to an intracellular niche, C. trachomatis has
evolved a notably reduced genome of ∼1 million base pairs that
supports a unique developmental cycle (Stephens et al., 1998).
This cycle typically involves two forms: infectious elementary
bodies (EBs) and dividing, metabolically active reticulate bod-
ies (RBs) (Moulder, 1991). Under stressful conditions in vitro,
however, C. trachomatis can enter into an alternative viable but
non-dividing growth form, termed a persistent growth form
(Beatty et al., 1994b). This persistent growth state extends the
host-bacterial relationship in vitro and has thus been proposed
to be linked to chronic infection and adverse outcomes, includ-
ing elicitation of tissue-damaging host responses, in vivo (Hogan
et al., 2004; Darville and Hiltke, 2010). Persistent forms are also
less responsive to antimicrobial therapy in vitro (Wyrick and
Knight, 2004; Reveneau et al., 2005) and in vivo (Byrne, 2001;
Phillips-Campbell et al., 2014). Several excellent reviews provide
extensively insightful descriptions of the chlamydial persistent
growth state and the potential to establish a chronic relationship
with the host (Beatty et al., 1994b; Hogan et al., 2004; McClarty
et al., 2007; Wyrick, 2010; Schoborg, 2011; Lo et al., 2012).
C. trachomatis growth exclusively takes place within an inclu-
sion, a membrane-bound vacuole. Despite the presence of this
barrier, C. trachomatis actively communicates with the host cells.
One method of interaction is the coordination of trafficking spe-
cific subsets of host vesicles to and from the inclusion, enabling
delivery of the inclusion components and nutrients required
for infection (Fields and Hackstadt, 2002). C. trachomatis also
secretes numerous effectors with host cell-modulating activities
across the complex membranes of the bacterium and the inclu-
sion or host cytoplasm to host cell compartments. Although
diverse secretory pathways, including the type II (Sec), type III,
and type V (autotransporter) secretion systems, have been shown
to play a role in the translocation of protein effectors (Crane
et al., 2006; Valdivia, 2008; Chen et al., 2010a; Mueller et al.,
2014), a mechanism for robust delivery of complex bacterial
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components to host cells is likely to be mediated by membrane
vesicles (MVs) that emerge from the envelope of growing bac-
teria (Giles et al., 2006; Giles and Wyrick, 2008; Wang et al.,
2011a; Frohlich et al., 2012). As part of bacterial growth and/or
envelope stress responses, the formation of MVs is a universal fea-
ture found in all Gram-negative bacteria (Beveridge, 1999; Kulp
and Kuehn, 2010), Mycobacterium spp. (Prados-Rosales et al.,
2011), and Gram-positive bacteria such as Bacillus spp. (Dubey
and Ben-Yehuda, 2011). Herein, we review recent findings on the
mechanistic aspects of bacterial adaptation to stress with a focus
on how C. trachomatis remodels its envelope, produces MVs, and
the potential important consequences of MV production with
respect to host-pathogen interactions.
MOLECULAR ARCHITECTURE OF THE CELL ENVELOPE
DURING THE CHLAMYDIAL DEVELOPMENTAL CYCLE
One of the critical developmental events common to Chlamydia
spp. is the ability of the organisms to adapt their envelopes
for the purpose of interacting with the host cell. Like other
Gram-negative bacteria, the C. trachomatis envelope consists of
an outer membrane (OM), an inner membrane (IM), and a
periplasm (Figure 1A). Recent elegant studies by several groups
have revealed that chlamydiae possess functional peptidoglycan
necessary for bacterial division, despite the lack of the cytoskele-
tal protein FtsZ (McCoy and Maurelli, 2006; Ouellette et al.,
2012; Pilhofer et al., 2013; Liechti et al., 2014). Nevertheless, a
unique feature of the chlamydial envelope, distinguishing them
from other Gram-negative bacteria, is the presence of a disul-
fide bond cross-linked major outer membrane protein (MOMP)
with the periplasmic localized OmcB and the lipoprotein OmcA
only in EBs (Hackstadt et al., 1985; Hatch, 1996). Both OmcB and
OmcA contain abundant cysteines. This cross-linkage is believed
to contribute to cell wall rigidity and osmotic stability of the EBs.
Proteins of the OM are important for various purposes includ-
ing envelope architecture, virulence, transport, cell division,
induction of inflammatory cytokine production, and immune
evasion (Hatch, 1996; Stephens and Lammel, 2001; Abdelsamed
et al., 2013). All of these tasks are presumably related to the gen-
eration and function of MVs that will be discussed in the later
sections of this review. MOMP is the most abundant surface-
exposed protein of both RBs and EBs (Caldwell et al., 1981; Hatch,
1996) and it functions as an adherin and a porin with its β-
barrel structure (Wang et al., 2006; Sun et al., 2007). MOMP also
has alternative conformations that may adapt to specific chlamy-
dial growth stages (Feher et al., 2013) and may impart different
levels of immunogenicity. Also located in the OM is a family
of polymorphic membrane proteins (Pmps) or autotransporters
unique to Chlamydia spp. (Stephens et al., 1998). C. trachomatis
encodes nine Pmps (PmpA-I) that are either temporally or con-
stitutively expressed (Tanzer and Hatch, 2001; Tan et al., 2010).
Such temporal expression may promote antigenic variation, tis-
sue tropism, and differential disease severity (Gomes et al., 2006;
Tan et al., 2009; Taylor et al., 2011; Abdelsamed et al., 2013).
Caldwell’s group has reported that PmpD is a species-common,
pan-neutralizing target (Crane et al., 2006). Other OM proteins
studied include plasmid encoded Pgp3 (Chen et al., 2010b), PorB
(Kubo and Stephens, 2000), HSP70 (DnaK) (Raulston, 1995),
FIGURE 1 | (A) A schematic diagram of the envelope structure of C.
trachomatis. Showing are the representative OM associated components
[Lipopolysaccharide (LPS), peptidoglycan (PG), MOMP, Pmps, OmcA,
OmcB, and Omp85], and putative chaperone and protease in the periplasm
in EBs. The potential process of MOMP or other OM protein transport
across the inner membrane via the Sec pathway, and insertion and
assembly into the OM is indicated. (B) Immunoblot of C. trachomatis
serovar F Omp85. Similar to MOMP, Omp85 is present in both EBs and
RBs as a component of the OM complex (OMC), however, OmcB exists
only in EBs. The OMCs were prepared from the insoluble fraction of
isolated EBs or RBs in phosphate buffered saline containing 2% Sarkysol as
described previously (Caldwell et al., 1981). The lysates of EBs and RBs,
and their OMCs were dissolved in Laemmli sample buffer (1:1, v:v)
supplemented with 5% 2-mercaptoethanol, 10mM dithiothreitol and
heated for 10min at 100◦C, isolated on 10% SDS-PAGE, followed by
immunoblotting using polyclonal antibodies to Omp85 or OmcB, and a
monoclonal antibody to C. trachomatis serovar F MOMP.
and Omp85 (YaeT) (Stephens and Lammel, 2001) that exists in
both EBs and RBs (Figure 1B) (Liu et al., 2010). In bacteria,
Omp85 facilitates the insertion of assembly intermediates from
the periplasm to the OM (Ricci and Silhavy, 2012).
Many chlamydial envelope components are ligands recognized
by host pattern-recognition receptors that induce inflammatory
cytokine production and generate adaptive immune responses
(Wang et al., 2010; Taylor et al., 2011; Abdelsamed et al., 2013).
Some envelope components may also contribute to immune eva-
sion. To this end, several chlamydial envelope components have
been considered vaccine candidates (Crane et al., 2006; Schautteet
et al., 2011; Hafner et al., 2014). Chlamydia spp. may quan-
titatively or qualitatively change their envelope structures as a
result of adaptation to developmental signals or environmental
cues (Beatty et al., 1994b; Hatch, 1996; Carrasco et al., 2011).
The plasticity of the envelope has important implications for the
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design of control strategies against bacterial infection because of
its importance in determining susceptibility to host defenses and
antibiotics (Tan et al., 2009; Hurdle et al., 2011).
STRESS INDUCES DRAMATIC CHANGES IN CHLAMYDIA
SPP. IN VITRO
Matsumoto and Manire described the first ultrastructure of an
aberrant RB form induced by penicillin in C. psittaci-infected
L929 cells as viewed by transmission electron microscopy (TEM)
(Matsumoto and Manire, 1970). They found that, in the pres-
ence of penicillin, RBs no longer divided, the RB to EB transition
was disrupted, and aberrant multinucleated RBs accumulated.
Concurrently, abundant vesicles were pinched off the aberrant
RBs. Removal of penicillin allowed for the chlamydiae to reenter
a normal growth state. Many elegant studies since have revealed
that the viable but nondividing altered persistent form occurs
when Chlamydia spp. are exposed to a variety of stress condi-
tions. These include IFNγ (Beatty et al., 1994a), sub-inhibitory
concentrations of antibiotics (Engel, 1992; Wyrick and Knight,
2004), nutrient deprivation (Beatty et al., 1994a; Raulston, 1997;
Harper et al., 2000), co-infection with either herpes simplex virus
(Vanover et al., 2008; Prusty et al., 2012) or Toxoplasma gondii
(Romano et al., 2013) in vitro, and infection with Chlamydia-
phage (Hsia et al., 2000). These stressors are often encountered
by pathogens during infection in vivo (Wyrick, 2010). IFNγ,
one of the stressors commonly studied, is a key component of
immunity to intracellular pathogens. IFNγ induces expression of
indoleamine-2, 3dioxygenase (IDO) that catalyzes the initial step
in the degradation of L-tryptophan to N-formylkynurenine and
kynurenine in eukaryotic cells (Beatty et al., 1994a). Such tryp-
tophan depletion profoundly interferes with chlamydial growth,
which, depending on the IFNγ concentration and exposure time,
induces the bacteria to enter into a persistent growth form or
results in bacterial eradication. Exposure to β-lactam antibiotics is
another well-studied stressor that causes chlamydiae to enter into
a persistent growth state and is used in simulating an inadequate
antimicrobial treatment of chlamydiae infection (Matsumoto
and Manire, 1970; Gerard et al., 2001; Giles and Wyrick, 2008;
Carrasco et al., 2011; Wang et al., 2011a; Ouellette et al., 2012;
Phillips-Campbell et al., 2014). Chlamydia spp. have a wide range
of responses to stress. A clear shift of gene expression profiles spe-
cific to each stressor has been consistently found in many host
cell types (Beatty et al., 1993, 1994b; Gerard et al., 2001, 2013;
Molestina et al., 2002; Belland et al., 2003a,b; Ouellette et al.,
2006; Lo et al., 2012). Changes in gene expression induced by
stress at the levels of transcription and translation are consistent
with the nature of a persistent growth form that undergoes DNA
replication, but not division by binary fission. Interestingly, IFNγ
exposure resulted in a global transcriptional upregulation lack-
ing increased translation in chlamydiae (Ouellette et al., 2006). In
contrast, penicillin exposure induced an alteration in transcrip-
tion coupled to a change in translation (Ouellette et al., 2006).
These data support that the impact of each stressor on bacteria is
mediated by different mechanisms, and the bacterial response to
each stress may be distinct.
To explore the mechanisms by which C. trachomatis sur-
vives under persistence inducing conditions, we utilized human
primary endocervical epithelial cells, the main site of C. tra-
chomatis infection in vivo. We found that normal C. trachoma-
tis forms could develop in cultured primary cells similarly to
HeLa cells (Wang et al., 2011a). Figures 2A–C show that expo-
sure to ampicillin or IFNγ led to aberrant RB phenotypes and
an accumulation of abundant MVs generated by C. trachoma-
tis in cultured cells. Additionally, confocal microscopy and cell
fractionation analyses demonstrated that the secreted chlamy-
dial T3S effectors, CopN and Tarp, and the secreted protease,
CPAF (Zhong et al., 2001) were decreased in ampicillin-induced
persistent forms (Wang et al., 2011a), the latter of which is
consistent with previous observations using IFNγ exposure or
iron-deprivation persistence models (Shaw et al., 2002; Heuer
et al., 2003). Changes in the spectrum of host cytosolic chlamydial
proteins may underlie the host-pathogen relationship because
of their importance in modulating host cell signaling (Valdivia,
2008; Zhong, 2011; Mueller et al., 2014).
MV PRODUCED DURING BACTERIAL INFECTION ARE
PRESENT IN C. TRACHOMATIS INFECTED CELLS IN VIVO IN
HUMANS
We have been particularly intrigued by the observed vesicular
structures that are derived from both pathogen and host cells
during C. trachomatis infection in culture, as they may serve as
a vital element for host-pathogen interactions. C. trachomatis is
likely to encounter numerous known and not-yet-identified con-
ditions in vivo. Of these, varying levels of IFNγ in the endocervix
during chlamydial infection in vivo are likely crucial as demon-
strated by studies in vitro, in animal models, and in observational
studies in humans (Arno et al., 1990; Beatty et al., 1994a; Byrne,
2001; Aiyar et al., 2014; Lewis et al., 2014). The direct involvement
of persistent growth forms in pathogenesis in vivo in humans
is challenging to prove, but several TEM studies have visualized
atypical pleomorphic RBs and aberrant C. trachomatis forms in
individuals with chronic infections, in Fallopian tube tissues, and
in the synovium of reactive arthritis patients (Patton et al., 1994;
Nanagara et al., 1995; Mazzoli et al., 2000; Bragina et al., 2001).
Very recently, the Quayle laboratory developed methodology to
sample endocervical cells and components of the endocervical
environment in C. trachomatis infected women. By using a cyto-
brush to retrieve cells followed by immediate placement of these
brushes in modified TEM fixative, the ultrastructure of “in vivo”
chlamydial growth forms in endocervical epithelial cells could
later be visualized by TEM (Lewis et al., 2014). These TEM analy-
ses revealed that chlamydial infection in the human endocervix
could result in a variety of inclusion types, containing normal
forms, a mixture of relatively “normal” and aberrant forms, or
inclusions with highly aberrant forms, and this varies between
patients (Lewis et al., 2014). Since MVs are so small in size
and lack unique biological markers for identification by standard
immunostaining techniques, we have begun to take advantage of
these samples to examine MV production in vivo. High mag-
nification TEM images were obtained from cross sections of
several inclusions and indicated the in vivo presence of C. tra-
chomatis MVs in inclusions sampled from two different patients
(Figures 3A–D). MVs appeared to be single membrane structures
and apparently associated with the OM of chlamydial organisms
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FIGURE 2 | Micrograph of chlamydial MVs in cultured human cervical
epithelial cells. (A) Ampicillin-induced persistent growth forms in infected
human primary endocervical epithelial cells. (B) A high magnification image
showing ampicillin-induced C. trachomatis MVs. The boxed MVs are enlarged
in the insert. (C) IFNγ-induced C. trachomatis MVs in infected HeLa cells. The
boxed bacterial membranes and the MVs are enlarged in the insert. Note: the
vesicles appear to be single-membrane structures different from the double
membrane structures of intact chlamydial organisms. They are associated
with the bacterial surface, clustered or scattered within the inclusion lumen.
Arrows indicate persistent forms. The primary cell cultures were established
from endocervical tissue explants as previously described (Herbst-Kralovetz
et al., 2008). Cells were infected with serovar F EBs resulting in a 30%
infection rate. Ampicillin (10μg/ml) was added to the culture at 16 h
post-infection. For the IFNγ exposure model, HeLa cells were exposed to
RPMI 1640 medium containing 50 units/ml of IFNγ for 24 h prior to infection.
Fresh IFNγ-containing medium was added after infection. Cells were
harvested at 36 h post-infection, fixed and processed for TEM as described
previously (Belland et al., 2003a). Scale bars: (A) 500nm. (B,C) 200 nm.
similar to those observed in vitro (Figure 2). The double mem-
brane structures of C. trachomatis forms are intact, which is an
indication of faithful sample preservation. This preliminary but
novel observation provides an important link to those observa-
tions made in vitro, indicating that MVs are a component of C.
trachomatis infection in vivo in humans. Further examination
of samples using this methodology is in progress to determine
the relationship between MV formation and the bacterial growth
state in natural human infections.
THE IMPORTANCE OF MVs DURING C. TRACHOMATIS
INFECTION
The best-studied mechanism that is related to OM changes
in Gram-negative bacteria is the formation of MVs during
both physiological adaptation and responses to envelope stress.
Bacterial MVs are not only compositionally similar to the
OM, containing LPS, phospholipids, and OM proteins, but
also contain selective periplasmic or cytoplasmic components,
such as toxins, DNAs, and RNAs, depending on the strain
(Kadurugamuwa and Beveridge, 1999; Beveridge, 1999; Kuehn
and Kesty, 2005). Research demonstrates the potential of MVs
as vehicles of pathogenicity, as they can deliver complex bacte-
rial molecules to target cells (Kuehn and Kesty, 2005; Bomberger
et al., 2009; Amano et al., 2010; Elmi et al., 2012). The MVs also
involve immune activation or suppression, stress responses, and
attachment and internalization of the bacteria. Because of the
cargo carrier nature and potent built-in adjuvanticity of most
MVs studied to date, they are being utilized as vaccines (Collins,
2011; Unal et al., 2011). Engineered MVs in E. coli have exhibited
a promising robust and tunable platform for the development of
recombinant multivalent vaccines (Chen et al., 2010c; Bartolini
et al., 2013).
Although chlamydial MVs were first observed over four
decades ago (Matsumoto and Manire, 1970; Stirling and
Richmond, 1980), the implications of these multi-functional
MVs are only beginning to be elucidated (Giles et al., 2006; Giles
and Wyrick, 2008; Wang et al., 2011a; Frohlich et al., 2012).
A puzzle remains with regard to what role chlamydial MVs
play during infection. Research data, including our own, sug-
gest that the generation of chlamydial protein containing MVs
occurs during productive infection and is enhanced by stress
(Figures 2, 3) (Matsumoto and Manire, 1970; Giles et al., 2006;
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FIGURE 3 | Micrograph of chlamydial MVs in cervical epithelial cells
from C. trachomatis infected patients. (A,B) Presence of C. trachomatis
vesicles associated with an aberrant C. trachomatis form in an inclusion.
Vesicles appeared in the form of a chain or single round vesicular structures.
This sample was obtained from a patient (patient 2) presented in Lewis
et al. in this journal (Lewis et al., 2014); (C,D) presence of C. trachomatis
MVs associated with a normal C. trachomatis form in an inclusion obtained
from an epithelial cell from a second C. trachomatis infected patient. C.
trachomatis infected human epithelial cells were collected by cytobrush
from patients with an NAAT and culture positive C. trachomatis infection,
and were immediately placed in a modified TEM fixative (Lewis et al., 2014)
(currently under review for this Journal) and processed as previously
described (Belland et al., 2003a). Scale bar = 500nm.
Giles and Wyrick, 2008; Wang et al., 2011a; Frohlich et al., 2012).
The presence of MVs, not only during the β-lactam induced
aberrant state, but also during both tryptophan starvation via
IFNγ exposure and in vivo infection demonstrate a universal
mechanism that appears to be responsive to stress rather than
merely a by-product of dysfunctional membrane biogenesis dur-
ing β-lactam exposure.
PROTEIN COMPOSITION OF CHLAMYDIAL MVs
A challenge to studying chlamydial MVs is the obligate intracel-
lular lifestyle of C. trachomatis and the complexity of isolating
vesicle populations derived from the pathogen as opposed to
the host cells. To more comprehensively understand the prop-
erties of chlamydial MVs, we developed a method that permits
efficient isolation and enrichment of intact chlamydial MVs for
biochemical analysis (Frohlich et al., 2012). This approach uses
a combination of nitrogen cavitation, magnetic bead immuno-
logical capture, and isopycnic centrifugation of C. trachomatis
infected L929 cells. This method not only allows for the study
of MVs, but also isolation of chlamydial forms, host organelles,
and host cytoplasm. Therefore, a “snapshot” of the total host
and chlamydial environments can be obtained from a single
experiment.
The integrity of chlamydial MVs isolated by this approach was
confirmed by TEM analysis (Figure 4) (Frohlich et al., 2012).
MOMP and several important C. trachomatis cytotoxic and/or
secreted proteins (CPAF, Pgp3, CT159, and CT166) are found
to be associated with MVs induced by ampicillin as determined
FIGURE 4 | Compositional analysis of C. trachomatis MV fractions. (A)
Micrographs of isolated MV fractions from C. trachomatis infected L929
cells by method described previously (Frohlich et al., 2012). At the
ultrastructural level, the MVs show heterogeneity in their size and
morphology. Scale bar = 500nm; (B) C. trachomatis (Ct) or host cell
proteins detected by immunoblotting with the lysates of infected cells,
EBs, chlamydial MVs, and the control vesicles from mock infected cells.
Note: coexistence of host ER marker (calnexin) with selective chamydial
proteins (MOMP, CPAF, CT159, and CT160). Proteins were separated by
12% SDS-PAGE, followed by immunoblotting with antibodies to the protein
of interest as described previously (Frohlich et al., 2012).
by immunoblotting analyses (Figure 4) (Frohlich et al., 2012).
These data support that MVs are generated by C. trachomatis as a
means of carrying and delivering chlamydial proteins or antigens.
Since those factors identified as being associated with chlamy-
dial MVs often also stimulate traditional secretion pathways, it
is possible that MV delivery provides an alternative and specific
mode of protein delivery. It has been proposed that transloca-
tion of chlamydial proteases, CPAF and HtrA, from the bacterial
cytoplasm to the periplasm is Sec-dependent (Wu et al., 2011;
Zhong, 2011), but secretion of these proteins to an extrabacte-
rial location or the host cytosol is likely mediated by MVs. One
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could envision a stress or developmental cycle-specific alterna-
tive protein delivery system employed to further circumvent host
processes designed to limit chlamydial growth. Interestingly, evi-
dence supports the association of chlamydial protein-containing
MVs with the endoplasmic reticulum (Giles and Wyrick, 2008;
Frohlich et al., 2012). Considering the widespread strategy of
chlamydial exploitation of host cellular machinery, it is likely that
the delivery of chlamydial proteins to the host by MVs, at least in
some cases, hijacks the host cells’ own protein delivery systems to
provide a targeted and specific localization of chlamydial proteins.
Further experimentation is needed to confirm and understand
these processes.
POTENTIAL FUNCTIONS OF CHLAMYDIAL MVs IN INFECTED HOST
CELLS—CARGO DELIVERY
Although the exact destination of MVs is difficult to determine,
TEM in combination with biochemical and immunodetection
analyses suggest that MVs can connect with bacterial cells, accu-
mulate in the inclusion lumen, associate with the inclusion mem-
brane, evert from but still associate with the inclusion, and be
found beyond the confines of the inclusion (Giles et al., 2006;
Giles and Wyrick, 2008). Previous studies have suggested that
a subset of these vesicles are antigen-containing structures that
emerge from the inclusionmembrane to release antigens from the
inclusion without the need for inclusion disruption (Richmond
and Stirling, 1981; Giles et al., 2006). These vesicles appeared
to contain inclusion membrane proteins (Incs) co-localized with
C. trachomatis antigens, including MOMP, LPS, GroEL2, and
GroEL3, but not GroEL1 (Giles et al., 2006). We found that the
isolated MV fraction was rich in CPAF, Pgp3, CT159, and CT166
(Frohlich et al., 2012). The functions of these proteins relating to
chlamydial virulence or modulating host cellular functions have
been studied (Belland et al., 2001; Zhong et al., 2001; Chen et al.,
2010b; Thalmann et al., 2010). It is possible that distinct subpop-
ulations are trafficked through cellular machinery alongside host
vesicles. Presumably, the release of bioactive contents mediated
by MVs influences the fate of host cells. How does MV transloca-
tion across the inclusion membrane and cytosol and/or surface of
the host cell occur? How do these chlamydial antigen-containing
vesicles influence host cell signaling and antigen presentation? Is
the generation of MVs eliciting a variety of specific and highly
regulated adaptive responses to protect C. trachomatis from the
offending stress, or do they modulate innate and/or adaptive
immunity? DoMVs produced byC. trachomatis relate to exosome
formation by cervical epithelial cells with C. trachomatis infec-
tion? Certainly, any one of these events alone or in concert would
confer a selective advantage in adaptation to and survival in the
ever-changing intracellular niche.
THE POTENTIAL ROLE OF MVs IN THE INNATE IMMUNE RESPONSE
The MVs derived from many Gram-negative bacteria are heav-
ily laden with complexes of pathogen-associated molecular pat-
terns, such as LPS, flagellin, CpG DNA, and virulence factors.
These MVs are strongly recognized by the host immune sys-
tem, resulting in the upregulation of pro-inflammatory cytokine
secretion (Amano et al., 2010; Kulp and Kuehn, 2010). To
determine if chlamydial MVs, induced by ampicillin, elicit an
innate immune response, we investigated the impact of iso-
lated MVs on the secretion of cytokines by epithelial cells. An
immortalized human endocervical epithelial cell line (A2EN)
infected with C. trachomatis was used as our model of infec-
tion. A2EN cells retain site appropriate expression of hormone
receptors, responsiveness to exogenous hormone stimulation,
expression of TLRs, and responsiveness to TLR agonists by secret-
ing cytokines, chemokines, and anti-microbial peptides (Buckner
et al., 2013).MVs isolated from C. trachomatis infected cell cul-
tures exposed to ampicillin were added to monolayers of A2EN
cells. Purified host cell vesicles without C. trachomatis infec-
tion, heat-killed Pseudomonas aeroginosa PAO1, and A2EN cells
productively infected with chlamydial organisms were used as
controls. Culture supernatants were collected at 24 and 48 h.
Chlamydial MVs induced a modest, albeit statistically significant
(p = 0.0230 based on performing a One Way ANOVA with a
Bonferroni post-test), 2-fold increase in CXCL-8 at 24 h com-
pared to the mock MV control, although, no significant increase
of IL-6, TNF-α, or GM-CSF was observed (Figure 5). At 48 h,
however, the differences observed were not significant as both
chlamydial MVs and the mock vesicle control induced a simi-
lar increase in CXCL-8 and GM-CSF levels, perhaps due to the
species differences between the mouse L929 derived vesicles and
the human A2EN cells. As previously published, C. trachomatis
infection in A2EN cells failed to upregulate secretion of CXCL8
(Buckner et al., 2013). Productive infection with C. trachomatis
conducted at the same time as the MV experiments recapitulated
these published observations and provided an additional control
lending to the consistent response of A2EN cells across differ-
ent laboratories (data not shown). These data suggest that MVs
have more capacity to elicit an innate immune response than
productive chlamydial infection, and that the molecules on the
surface or contained within these vesicles may be structurally dis-
tinct compared to those present on or within whole chlamydial
particles. The significance of such an early (at 24 h) but weak stim-
ulatory effect on endocervical cells by chlamydial MVs remains
to be determined. These results are clearly different from previ-
ously reported observations with MVs from other Gram-negative
bacteria, as MVs derived from these other bacteria induce a
robust and significant increase in pro-inflammatory cytokines
and chemokines and induce antibody production (Amano et al.,
2010; Nakao et al., 2011; Sharpe et al., 2011; Zhao et al., 2013).
However, given the obligate intracellular nature of C. trachoma-
tis, a robust immune response would not likely be favorable to
continued or long-term infection. These results support other
observations of immune-evasion tactics used by chlamydiae, even
in the delivery of MVs.
THE POTENTIAL ROLE OF MVs IN EXCHANGE OF GENETIC MATERIALS
It has been demonstrated that bacterial MV production provides
a general advantage for survival and social networks in many bac-
teria species (Kuehn and Kesty, 2005; Amano et al., 2010; Bielig
et al., 2011; Unal et al., 2011). Of great interest to the study ofMVs
is their participation in inter- and intra-species exchange of bac-
terial material in addition to their immuomodulatory functions
(Kadurugamuwa and Beveridge, 1999; Renelli et al., 2004; Chiura
et al., 2011; Barteneva et al., 2013). MVs may bind to bacterial
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FIGURE 5 | Cytokine response of A2EN cells to vesicles isolated from a
C. trachomatis infection of L929 cells. MVs isolated from C. trachomatis
infected cell cultures exposed to ampicillin (10μg/ml) were added to a
monolayer of A2EN cells. Purified host cell vesicles from a mock infection,
heat-killed Pseudomonas aeroginosa PAO1 (Pa), and A2EN cells
productively infected with chlamydial organisms were used as controls.
Cytokine measurements were made using multiplex analyses as previously
described (Buckner et al., 2013). ∗p = 0.0230. The red dashed line
represents baseline control values.
or host cells, fuse with the target cell membrane, and deliver
their cargo to the cytosol of the target cells. Recent evidence
that protein and DNA transfer between distantly related species
raises the prospect of a widely distributed mechanism of bacterial
communication (Dubey and Ben-Yehuda, 2011). This poses an
interesting potential for C. trachomatis given the vast sampling of
both normal and pathogenic microorganisms potentially inhab-
iting the same niche in the genital tract and could potentially
provide a significant adaptation and survival advantage.
While there is no evidence that chlamydial MVs deliver prod-
ucts to other species, it is possible that MVs could be used
to deliver not only proteins but also genetic materials among
chlamydiae. Recently, it has become evident that Chlamydia
spp. have all the necessary recombination machinery despite an
inclusion-confined lifestyle (Zhang et al., 1995; Demars et al.,
2007; Joseph et al., 2011; Harris et al., 2012). Recombination has
been documented between strains with different tissues tropisms,
the lymphogranuloma venereum with the urogenital biovars,
and within different genital strains in vitro and in vivo (Jeffrey
et al., 2010, 2013; Harris et al., 2012). Whole genome sequencing
analyses with a collection of diverse clinical isolates and labora-
tory strains have revealed that the recombination or mutation
events often occur in several regions of the chromosome encoding
surface-exposed proteins, such as MOMP, Pmps and the T3S sys-
tem effector Tarp (Gomes et al., 2004; Brunelle and Sensabaugh,
2006; Gomes et al., 2006; Joseph et al., 2011; Harris et al.,
2012). Different C. trachomatis strains can recombine following
mixed infection for a relatively short time period in vitro (Jeffrey
et al., 2013). Their potential capabilities for DNA exchange might
explain, at least in part, the acquisition of virulence genes and
fitness traits, as well as variations in these surface exposed pro-
teins. Whether or not MVs directly contribute to the horizontal
gene transfer between chlamydial organisms, as is observed in
other bacteria, is unknown, but it begs the question: what impact
does MV-mediated cell-to-cell communication have on patho-
genesis and bacterial survival within the host? How might these
MVs directly or indirectly affect the genital tract microbiome?
Further addressing these questions will help in understanding the
occurrence of antigen variation and diversity in C. trachomatis
during infection and promote the development of novel genetic
tools to study genetics and pathogenesis of C. trachomatis.
MOLECULAR MECHANISMS CONTROLLING MV FORMATION
IN C. TRACHOMATIS
Despite tremendous efforts, mechanisms by which bacteria pro-
duce MVs while sustaining their viability remain unclear. Based
on studies in model organisms, including P. aeruginosa and E.
coli, several mechanisms of MV formation have been proposed.
First, the loss of OM-PG cross-links may allow excess lipid forma-
tion to induce MV formation. Second, accumulated periplasmic
proteins simply push out the OM, trapping large amounts of pro-
tein inside the resulting vesicle. Third, the involvement of integral
membrane proteins or signal molecules [such as Pseudomonas
quorum sensing (PQS) molecules] induces membrane curvature
and vesiculation (Schertzer andWhiteley, 2012). Fourth, the pres-
ence of rough LPS in bacteria contributes directly and indirectly
to the formation of MVs (Kadurugamuwa and Beveridge, 1995;
Sabra et al., 2003). Finally, genetic mechanisms may exist to regu-
late MV formation (McBroom et al., 2006; Schwechheimer et al.,
2013). These MV inducing factors that have been proposed may
not be mutually exclusive, and multiple dynamic surface compo-
nents may contribute to MV production in bacteria (Kulp and
Kuehn, 2010; Schwechheimer et al., 2013).
We know surprisingly little about OM biogenesis, and even
less is known about the related vesicle formation in C. trachoma-
tis. It is likely that after synthesis in the bacterial cytoplasm,
chlamydial protein translocation to the OM involves complex
steps conserved in Gram-negative bacteria (Hagan et al., 2010;
Silhavy et al., 2010). These include: (i) translocation across the
IM via the Sec pathway; (ii) folding facilitated by periplasmic
chaperones/proteases, and (iii) assembly and insertion into the
lipid phase of the OM, a process facilitated by a β-barrel assem-
bly machine (BAM) complex that consists of Omp85 and its
interacting lipoproteins (Ricci and Silhavy, 2012). Also necessary
for maintenance of EB envelope integrity is the disulfide bond
cross-linking of MOMP with OmcA and OmcB (Hatch, 1996).
We hypothesize that both bacterial and host factors contribute
to the generation and release of MVs from C. trachomatis. We
envision different mechanistic scenarios involved in MV forma-
tion during productive infection or the persistent growth state
induced by ampicillin. In the case of productive infection, MV
generation may reflect local OM deformation and/or a physi-
ological turnover of envelope components because of envelope
remodeling, a critical process in chlamydial development. In fact,
RB multiplication and division require a rapid surface expansion
or alteration achieved by the synthesis, assembly, and insertion
of lipid or non-lipid OM components, while transition from a
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large RB to a small EB undergoes the opposite. In contrast, ampi-
cillin induced hyper-vesiculation phenotypes may be the result
of an envelope stress response. Exposure to ampicillin blocks RB
division, although DNA replication remains. These can, in turn,
result in attenuation of OM protein expression, accumulation of
misfolded proteins in the periplasm, activation of proteolytic pro-
cesses, and interference with the correct assembly and insertion
of proteins in the OM. All of these are likely to induce height-
ened vesiculation. MV formation may offer a means to remove
stress caused by the accumulated “toxic” waste or unfolded pro-
teins. Chlamydial HtrA, a key player in envelope stress response
(Huston et al., 2007, 2008; Zhong, 2011), is likely to play a role in
controlling the formation of MVs, as is observed in other bacteria
(McBroom et al., 2006). Given the strong capacity of chlamydial
exploitation of host cellular machinery, MV cargo delivery may
partially depend on a yet to be defined host trafficking pathway.
Whether or not a potential host factor contributes to the forma-
tion of chlamydial MVs remains to be determined. Nevertheless,
studying molecular mechanisms underlying envelope adaptation
to development or stress offers a powerful tool and new route
to understanding how C. trachomatis adapts to and survives in
nutrient rich but hostile intracellular niches.
SUMMARY AND PERSPECTIVE
The production of MVs in bacteria is a universal mechanism
whereby virulence factors, signaling molecules, and genetic mate-
rials can be packaged and effectively transported to target cells.
Major challenges in the field of vesicle research with obligate
intracellular bacteria include (i) developing new comprehensive
approaches for vesicle isolation and characterization, (ii) iso-
lating pure populations from bacteria or host cells, and (iii)
monitoring vesicle dynamics under physiologic relevant condi-
tions. Nevertheless, the information already available indicates
that MVs produced during chlamydial infection are present in
cultured cell lines, primary human endocervical epithelial cells
infected with C. trachomatis, and more importantly, in clinical
specimens from C. trachomatis infected patients. These data pro-
vide preliminary evidence that theMV is a component of chlamy-
dial infection in vivo. We hypothesize that C. trachomatis varies
OM organization and produces MVs during the developmental
cycle and in response to stress.Manymysteries remain with regard
to how MVs contribute to host-pathogen interactions, the rela-
tionship of developmental envelope biogenesis within the context
of MV formation and regulation, and the modes of MV cellular
targeting and delivery. Improved understanding of the mecha-
nisms of MV mediated mass material exchanges and the effects
on C. trachomatis survival may have relevance to several impor-
tant aspects of chlamydial biology, including the C. trachomatis
persistent growth state in vivo. Recent progresses in chlamydial
genetics may have great potential to inspire significant advance in
MV studies in C. trachomatis (Wang et al., 2011b; Gérard et al.,
2013; Gong et al., 2013; Song et al., 2013; Bauler and Hackstadt,
2014). Since global control of C. trachomatis infection will best
be achieved with a vaccine, developing a greater understanding of
the functional role and the mechanisms of envelope modification
and MV production may open new therapeutic avenues against
this medically important intracellular bacterium.
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